FDA Commissioner Pool: McClellan Fits Non-Industry Profile; Is That Enough?
Executive Summary
White House economic advisor Mark McClellan's viability as the next FDA commissioner hinges on Senate Health Committee Chairman Edward Kennedy's (D-Mass.) willingness to look beyond the internist's strong ties to the Bush Administration
You may also be interested in...
FDA Commissioner McClellan? HHS’ Thompson Says Nomination Is Imminent
The Bush Administration appears ready to move forward with the nomination of health advisor Mark McClellan, MD/PhD, as FDA commissioner
FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says
FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says